Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyrimidines >  Chloropyrimidine >  4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine

4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine

Basic information Safety Supplier Related

4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine Basic information

Product Name:
4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine
Synonyms:
  • 100217
  • 4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine
  • 7H-Pyrrolo[2,3-d]pyrimidine, 4-chloro-5-methyl-
  • 4-Chloro-5-Methyl-7H-pyrr...
CAS:
1618-36-6
MF:
C7H6ClN3
MW:
167.6
Product Categories:
  • Heterocycle-Pyrimidine series
Mol File:
1618-36-6.mol
More
Less

4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine Chemical Properties

Melting point:
227-228 °C (decomp)
Boiling point:
280 °C
Density 
1.51
Flash point:
123 °C
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
form 
solid
pka
11.75±0.20(Predicted)
color 
Yellow
More
Less

Safety Information

HS Code 
2933599590
More
Less

4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine Usage And Synthesis

Synthesis

22276-95-5

74-88-4

1618-36-6

The general procedure for the synthesis of 4-chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidines from 5-bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidines and iodomethane was as follows: n-butyllithium (4.08 mL, 6.52 mmol) was slowly added dropwise under nitrogen protection to a solution of 5-bromo-4-chloro-7H-pyrrolo[2,3-d]pyrimidines (689 mg. 2.96 mmol) in a solution of tetrahydrofuran (40 mL), keeping the reaction temperature at -78 °C, and the dropwise addition time was controlled within 5 min. The resulting suspension was continued to be stirred at -78 °C for 30 min. Subsequently, methyl iodide (0.295 mL, 4.74 mmol) was added and the reaction mixture was allowed to slowly warm up to room temperature. After the reaction was completed, the reaction mixture was diluted with water (25 mL) and extracted with ethyl acetate (50 mL). The organic layer was washed with brine (25 mL), dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to give the crude product. The crude product was purified by fast silica gel column chromatography with isohexane/ethyl acetate as eluent (20% to 50% gradient elution). The pure grades were collected and concentrated to dryness under reduced pressure to afford 4-chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine (244 mg, 49.1% yield) as a white solid. The structure of the product was confirmed by 1H NMR (400.13 MHz, DMSO-d6) and mass spectrometry: 1H NMR δ 2.42 (3H, d), 7.43 (1H, d), 8.51 (1H, s), 12.22 (1H, s); MS m/z [M+H]+ 168.

References

[1] Helvetica Chimica Acta, 1994, vol. 77, # 4, p. 897 - 903
[2] Patent: WO2008/75109, 2008, A1. Location in patent: Page/Page column 115-116
[3] Patent: WO2008/75110, 2008, A1. Location in patent: Page/Page column 107-108
[4] Journal of Medicinal Chemistry, 1990, vol. 33, # 7, p. 1984 - 1992
[5] Patent: WO2012/80735, 2012, A1. Location in patent: Page/Page column 24

4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidineSupplier

JinYan Chemicals(ShangHai) Co.,Ltd.
Tel
13817811078
Email
sales@jingyan-chemical.com
Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Email
sales@chemreagents.com
Tetranov Biopharm
Tel
13526569071
Email
sales@leadmedpharm.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Shanghai Sunway Pharmaceutical Technology Co., Ltd
Tel
18270980682
Email
mlcheng@sunwaypharm.cn